Introduction
Optic neuritis is characterized by inflammation of the optic nerve, and is frequently but not always associ ated with multiple sclerosis (MS). 1 Once a patient is diagnosed with MS, visual symptoms may be summar ily attributed to an MS relapse, potentially missing other treatable aetiologies of visual loss. Transient problems such as conduction block might be mistaken for relapses of optic neuritis, 2, 3 and problems related to impaired eye movements may be overlooked. [4] [5] [6] Patients with forms of optic neuritis other than MSassociated optic neuritis (MSON)-including neuro myelitis optica (NMO) spec trum disorder and chronic relapsing inflammatory optic neuropathy (CRION)-must be recognized as early as possible, because these individuals are at risk of severe visual loss. 7, 8 In this Review, we emphasize that optic neuritis rep resents a pragmatic model for testing structuralfunctional relationships. 9, 10 The visual system is the best understood and most accessible part of the human CNS. In each eye, 100 million rod photoreceptors capture light, which is then converted by 12 types of bipolar cell into a digitally coded electrical signal, 11 which passes through the 1,158,000 axons of the optic nerve. 12 The nerve fibres decussate partially at the optic chiasm, synapse in the lateral geniculate nucleus, and finally project through the optic radi ations into the welldefined cytoarchitec ture of the visual cortex, 13 wherein plastic capabilities continuously shape our subjective visual experience. 14 A real opportunity exists to make use of this detailed knowledge in an increasingly complex diagnostic and therapeutic landscape. Table 1 summarizes the published criteria for a single episode of isolated optic neuritis (ION), 15 relapsing episodes of isolated optic neuritis (RION), 15 CRION, 7 MSON, 16 and optic neuritis as observed in NMO spec trum disorder. 8 No consensus has been reached on how to investigate patients who present with acute optic neur itis, and this Review aims to contribute to the develop ment of such a consensus. Protocols for standard care and research (Supplementary Figure 1 online) should take associated costs and resources into account.
History taking
A structured historytaking process should search for warning signs ('red flags') that suggest an alterna tive diagnosis to MSON (Box 1), thereby prompting further investigations.
The classic clinical presentation of optic neuritis consists of (peri)ocular pain, often retrobulbar, which frequently precedes loss of vision and is typically associ ated with dyschromatopsia. Pain that is exacerbated by eye movement suggests inflammation of the optic nerve adjacent to the ocular muscles. 17 Ocular pain or headache not worsened on eye movement, or painless optic neur itis, may indicate inflammation within the optic canal or intracranial space. In addition, positive phenomena such as phosphenes and scintillations can be present.
Following recovery from optic neuritis, patients might experience glare disability, reduced vision in bright light, visual fading, and/or the Uhthoff or Pulfrich phenomenon.
Uhthoff phenomenon
The symptoms and signs of optic neuritis can be aggra vated by a rise in body temperature due to exercise, taking a bath, fever due to infection, warm meals, cognitive and/ or emotional stress, or high ambient temperatures. This socalled 'Uhthoff phenomenon' is caused by transient conduction block, and is typically observed during the recovery phase of optic neuritis. 2, 3 Pulfrich phenomenon Perception of movement in depth may be difficult fol lowing optic neuritis-a condition termed the Pulfrich phenom enon. 18, 19 Patients might report problems with judging the course of vehicles or bicycles in moving traffic, pouring liquid into jars, or judging the trajec tory of a tennis or squash ball. We specifically ask whether these problems also occur if the patient is not moving, with best corrected visual acuity under bin ocular viewing conditions. The Pulfrich phenomenon is usually found in patients who have recovered from optic neuritis and exhibit good visual acuity, rather than in the acute situation.
Key points
■ Optic neuritis is frequently but not always associated with multiple sclerosis (MS), and patients who present with optic neuritis will want to know about their risk of developing MS ■ Early recognition of optic neuritis not caused by MS is important to prevent severe visual loss, and to avoid inappropriate use of MS-targeted treatments ■ No international consensus exists on the nosology of optic neuritis: the aetiology remains idiopathic in many cases, and attempts at classification fall short, in part because we lack a uniform investigation protocol ■ This Review on established and emerging diagnostic tools proposes a consensus on the investigation of patients with suspected optic neuritis in both standard care and research ■ The aims are to aid recognition of patients at risk of severe visual loss, to contribute to future attempts at classification of optic neuritis, and to provide end points for clinical studies
Clinical and bedside assessment
Standard care protocol An example of the diagnostic workup for a patient with optic neuritis is presented in Supplementary Figure 1 online and Box 2. The standard of care for optic neuritis includes meas urement of best corrected highcontrast visual acuity, preferably with a LogMAR retroilluminated chart. For conversion of the various acuity tests used around the world to a LogMAR value, see Supplementary  Table 1 online.
In each patient, retinal examination should be per formed by direct and indirect ophthalmoscopy. A pale optic disc, as shown in Figure 1a , is indicative of optic atrophy.
Monocular visual fields can be assessed clinically by confrontation using either finger movements or differ entially sized and coloured objects. 1 We use a 4 mm red pin and also test for red desaturation as an indicator of impaired colour vision. Testing for red desaturation can be performed by comparing central vision either between the two eyes (affected and unaffected) or regionally within different areas of the visual field of one affected eye.
We acknowledge that formal perimetry such as the SITA 242 protocol would be considered standard care in a well equipped neuroophthalmological service, but might not be readily available in a routine neurological outpatient department, and may not be well tolerated by all patients.
The swinging light test should be used to search for a relative afferent pupillary defect (RAPD, also known as Marcus Gunn pupil). The RAPD can be amplified by holding a 0.3 log unit neutral density filter in front of the affected eye. 20 An RAPD should be present in cases of unilateral optic neuritis, but can be absent in binocular simultaneous or sequential optic neuritis. If no RAPD is detected, a diagnosis can only be made with extreme caution. The test cannot be used if the optic neuropathy is bilateral and symmetrical. Pain on eye movements is one of the strongest indica tors of optic neuritis, and the few other conditions that manifest with this symptom-for example, myositis, orbital inflammation or subtarsal foreign body-can gen erally be excluded at the bedside by testing eyelid function and eye movements. Eye movements are best tested if the patient has sufficient visual acuity to focus on an appropri ately moving target. We examine smooth pursuit, saccades and vergence movements binocularly. We are looking par ticularly for evidence of slow adduction of one or both eyes on examination of horizontal saccades as evidence of subclinical internuclear ophthalmoplegia, which is highly suggestive of demyelination elsewhere in the CNS. 21 The cover-uncover test helps us to identify transient visual problems that might be attributable to a phoria.
Research protocol
Additional tests that are not routinely used because of time and financial constraints can be incorporated into research protocols for optic neuritis. Lowcontrast visual acuity can be tested with best correction using Sloan charts. 22 In addition, Pelli-Robson charts are useful for testing contrast sensitivity. Colour vision tests include, among others, the Ishihara Test, the Hardy-Rand-Ritter Pseudoisochromatic Plates, the Lanthony Desaturated D15 Test or, if time permits, the Farnsworth-Munsell 100 Hue Test. Both lowcontrast acuity and colour vision tests are sensitive for subtle impairment of visual func tion even years after the episode. Computerized testing of colour vision provides quantitative data. 23 Importantly, this approach also considers relevant ageadjusted normal limits of colour vision, which are required for reliable recognition of acquired problems. 23 Patients with the Pulfrich phenomenon can be assessed using a classic pendulum. 18, 19 A horizontal swinging pen dulum is perceived as following an ellipsoid trajectory by patients who exhibit this symptom. 24 The Pulfrich phenomenon is best assessed if the pendulum swings in front of a highcontrast patterned background, which enhances binocular disparity (stereoscopic vision).
Optical coherence tomography

Overview
Retinal optical coherence tomography (OCT) permits accurate documentation of changes in thickness of retinal layers. 25, 26 The full spectrum of retinal pathology that might be unravelled through the use of OCT in MS is not yet known, and new differential diagnoses are being added as the quality of OCT data improves. At present, recom mendations for standard care and research protocols for optic neuritis are based largely on two types of pathology. First, thinning or atrophy of the inner retinal layers-that is, the retinal nerve fibre layer (RNFL) and ganglion cell layer (GCL, Figures 1, 2 and 3 )-is commonly observed. Second, thickening or swelling of the peripapillary RNFL can be seen in cases with optic disc swelling. There might also be localized thickening of the inner nuclear layer (INL), which can be associated with microcystic mac ular oedema (MMO, also known as microcystic macular changes or retrograde maculopathy; [27] [28] [29] Figure 4 and Supplementary Video 1 online).
Thinning
Loss of the unmyelinated axons in the retina can readily be quantified by OCT, and is understood to represent several processes: 30 first, pathology in the retinal layers resulting in anterograde (Wallerian) degeneration, leading to thinning of the RNFL; second, pathology of the optic nerve, such as an acute optic neuritis attack, causing axonal transection and loss (direct retrograde degenera tion); and third, posterior visual pathway lesions that lead to thinning of the RNFL by trans synaptic (via the lateral geniculate nucleus) retrograde axonal degener ation. 
Box 2 | A case of relapsing isolated optic neuritis
A 35-year-old woman presented with blurred vision in her right eye for the second time in 3 months. Visual loss was preceded by several days with photopsia, but no pain on eye movements was reported. Uncorrected visual acuity in the right eye was 0.03 with a central scotoma. Oligoclonal bands were detected in the cerebrospinal fluid (CSF), and additional identical oligoclonal bands (OCBs) were found in CSF and serum ('type 3' or mirror plus pattern 67 ). CSF white cell count was elevated (25 per mm 3 ), with a normal total protein level (19 mg/l). The test for anti-aquaporin 4 antibodies was negative, as were the remaining autoimmune, infectious and metabolic laboratory investigations.
Fundus photography (Figure 1a) showed that the right optic disc was pale temporally, indicating optic atrophy, whereas the left optic disc was normal. The patient received intravenous steroids according to the optic neuritis treatment trial protocol, but her vision failed to improve over the subsequent 9 months. Serial optical coherence tomography measurements demonstrated the development of further peripapillary retinal nerve fibre layer (pRNFL) atrophy. Consistent with the photograph of the right optic disc, some pRNFL atrophy of the temporal nerve fibres was observed (thin black line in Figure 1d ). Atrophy of the pRNFL progressed over the subsequent 9 months and mainly affected the temporal fibres. Automated layer segmentation (Figure 1e -h) demonstrated only a very small degree of atrophy in the inner plexiform layer and inner nuclear layer. By contrast, more-global thickening developed in the outer retinal layers (Figure 1h ). This is a consistent finding in the literature, but its significance is unknown. In reality, axonotemesis in the hardwired visual pathways will always lead to bidirectional transsynaptic axonal degeneration. 33 One should allow a 3month interval after an acute attack of optic neuritis before attempting to quantify peripapillary atrophy of the RNFL. 34, 35 Wedge like thinning should prompt investi gation for vascular pathology, such as AION or Susac syndrome (Table 2) . 36 Occasionally, fluor escein angio graphy (FAG; Figure 1b ) may be required to further assess retinal blood flow and leakage. 37 RNFL and GCL atrophy is more severe in NMO and CRION than in MSON. [38] [39] [40] [41] [42] [43] Caution is required when interpreting data from patients with recurrent episodes, as moresevere thinning may be the result of cumulative damage.
Thickening
Disk swelling in the acute phase of optic neuritis is well recognized. 1, 35 Recent evidence indicates that MMO and thickening of the INL are more frequent in NMO than in MSON. 44, 45 Because of the association between MMO and NMO, we advocate testing for the presence of antiaquaporin 4 antibodies (AQP4IgG) in patients with MMO who experience relapsing optic neuritis, or in the presence of red flags (Box 1, Supplementary  Figure 1 
online).
MMO is not specific for either MS or NMO, and is also seen in RION, CRION and a range of other acute and chronic ophthalmological conditions (Figure 4) . 7, 27, [45] [46] [47] [48] [49] A large study involving 6,551 OCT scans from 1,370 patients indicated that MMO is transient in over 80% of cases, so we suggest longitudinal followup of patients who exhibit this sign. 47 In neuroretinitis, acute subretinal fluid and chronic exudates can be effectively visualized by OCT. 50 Standard care protocol The reviewed evidence suggests that incorporation of OCT findings into the standard care protocol for optic neuritis is likely to become routine. However, protocols still have to be validated and to stand the test of time in clinical practice. As a minimalistic protocol for stand ard care, we suggest obtaining two scans using a spectral domain retinal OCT system. The proposed scans-a peripapillary ring scan (Figure 2a ) and a macular volume scan (Figure 2b )-take 2-5 min per eye in patients who can maintain visual fixation. A difference of RNFL values of more than 20% between the two eyes may suggest a previous 'subclinical' episode. Macular scans should be carefully reviewed for the presence of MMO. 47 Research protocol All scans should fulfil rigorous established quality control criteria. 51, 52 A sharp image and high contrast between retinal layers is a prerequisite for image postprocessing and layer segmentation (Figure 2c) . In all cases, we advise acquisition of each scan with reference to a stored ref erence scan taken at baseline, so as to allow longterm followup of the macular ganglion cell complex analy sis and the peripapillary RNFL as sensitive measures for progressive neurodegeneration affecting the eye. A range of additional research techniques are available, such as en face OCT, polarizationsensitive OCT, adaptive optics, fluorescence labelling, and Doppler OCT. 30 
Laboratory investigations
Overview It is important to note that in most patients with typical MSON, there is no evidence to suggest a need for routine blood tests or cerebrospinal fluid (CSF) examination. 1 
Standard care protocol
Additional blood investigation is warranted in patients with an atypical presentation, such as lack of pain or severe visual loss (<6/60), bilateral visual loss, or severe disc swelling with haemorrhages, and/or with a relevant medical or family history. Blood tests can aid identification of conditions such as paraneoplastic optic neuropathy and cancerassociated retinopathy.
Metabolic pathology
In suspected metabolic conditions, which can be charac terized by bilateral and symmetrical visual loss, tests for vitamin B 12 , red blood cell folate and methylmalonic acid levels are recommended. 53 Note that low vitamin B 12 levels can coexist with NMO. 54 
Systemic pathology
For suspected systemic disease (see systemic and ischae mic aetiologies in Table 2 ), tests for haematology, electro lytes, liver function, erythrocyte sedimentation rate, Creactive protein and serum angiotensinconverting enzyme levels are advised.
Inflammatory pathology
Serological studies should be guided by the clinical history. Consideration should be given to syphilis, Lyme disease and Bartonella henselae (see infectious aetiologies in Table 2 ).
Immunological pathology
A resourcesaving screening approach to immunologi cal blood tests is to start with antinuclear antibodies (ANA), following the international guidelines. 55 In cases of ANA seropositivity, particularly in young patients, this test may be followed by a more targeted approach that includes assays for autoantibodies against extractable nuclear antigens, perinuclear antineutrophil cyto plasmic antibodies, cardiolipin and β2 glycoprotein 1. This approach facilitates the detection of autoimmune overlap syndromes, which occur in around 5% of patients with autoimmune disease. 56, 57 In one case, a patient with optic neuritis was found to be seropositive for antiGQ1b and antiGT1a IgG. 58 If orbital disease causing a compressive optic neuro pathy is suspected, thyroid function and antithyroid antibody tests should be requested. Tests for antiCRMP5 (also called antiCV2) and recoverin autoantibodies should be requested in patients with a history of cancer or suspected paraneoplastic disease, in order to identify conditions such as cancerassociated retinopathy.
In suspected NMO, stateoftheart assays for AQP4 IgG are recommended because of their high diagnostic specifi city (>95%) and sensitivity (77%). [59] [60] [61] Testing for AQP4IgG is advised in all cases with features atypical for MSON-in particular, severe relapsing or bilateral loss of vision-as AQP4IgG seropositivity has specific diagnostic and prognostic implications. 62, 63 Because of the hetero geneity of assays 61 and the possi ble harmful and ethical consequences of a falsenegative or false positive diagnosis of NMO-optic neuritis, we recommend that AQP4IgG detection should be per formed in laboratories that use validated assays with high sensitivity and specificity. Evidence exists, however, for a subgroup of patients with NMO who are AQP4IgG seronegative but myelin oligodendrocyte glycoprotein *Sinusitis was high up in the differential diagnosis in the past but has almost disappeared over the past few decades. 122 ‡ It is absolutely mandatory to obtain a good history including recent travels to high-risk areas for certain infections (malaria, dengue virus, West Nile virus, cysticercosis) or other forms of exposure. § A macular star is suggestive of neuroretinitis and can be associated with peripheral retinal haemorrhages and speckled appearance of the pigment epithelium. || Endemic optic neuropathies have been described in Cuba and Tanzania. Abbreviations: ACE, angiotensin-converting enzyme; ANA, antinuclear antibodies; ANCA, antineutrophil cytoplasmic antibodies; AZOOR, acute zonal occult outer retinopathy; CCF, carotid cavernous sinus fistula; CRP, c-reactive protein; CSF, cerebrospinal fluid; CTA, CT angiography; DSA, digital subtraction angiography; ECG, electrocardiogram; ERG, electroretinogram; ESR, erythrocyte sedimentation rate; GCA, giant cell arteritis; LHON, Leber hereditary optic neuropathy; MMA, methylmalonic acid; MRA, magnetic resonance angiography; OCT, optical coherence tomography; PION, posterior ischaemic optic neuropathy; SLE, systemic lupus erythematosus; VEP, visual evoked potentials.
IgG seropositive, so AQP4IgG seronegativity does not necessarily preclude a diagnosis of NMO. 64, 65 Cerebrospinal fluid CSF examination will occasionally be necessary in patients presenting with symptoms of optic neuritis, prin cipally when there is doubt as to the aetiology. CSF exami nation is rarely contributory in cases deemed to be MSON on other criteria. 16 The CSF examination should include cytology, total protein, glucose and oligo clonal bands. 66 Of note, CSF OCBs are not specific for MS, and might also be found in over 30 other conditions. 67 The type 2 OCB pattern, in which OCBs are found in the CSF but not in the serum, indicating isolated intrathecal oligoclonal IgG synthesis, is only found in about 10% of patients with NMO. 68, 69 However, CSF glial fibrillary acidic protein (GFAP) levels have a high sensitivity (85-100%) but low specificity (77-100%) for acute NMO. [70] [71] [72] [73] Research protocol In view of the emerging body of literature on the role of vitamin D deficiency as a risk factor for demyelination, testing of vitamin D levels is becoming increasingly rel evant for optic neuritis research. 74, 75 In addition, blood neurofilament levels might be of prognostic value in optic neuritis. [76] [77] [78] Standardized sample collection, processing, storage and analyses are mandatory to ensure highquality biomarker research, enable multicentre analyses, make use of historical cohorts, and safeguard against bias. 79 Collection of both plasma and serum is recommended. Samples should be well mixed prior to transport to the laboratory, and should be centrifuged at room tem perature (2,000 g for 10 min) within 1 h of sampling. In situations where a longer interval between sampling and processing can be expected, transport and storage at 4 °C is advised. Some biomarkers are sensitive to repeated freeze-thaw cycling, so we advise that each sample should be stored in at least four 500 μl aliquots at -80 °C.
We anticipate that the discovery of new autoanti bodies, in part through retrospective analysis of stored CSF, serum and plasma samples, will be relevant for the differential diagnosis of optic neuritis.
MRI
Overview
This section focuses on MRI of the optic nerves, which is complementary to the wellestablished literature on brain MRI. 80 MRI of the optic nerves helps us to rule out alternative diagnoses, demonstrate optic nerve inflam mation, and conduct research into the assessment of optic nerve damage and atrophy.
Classic MRI findings in acute optic neuritis are highsignalintensity lesions in the optic nerve (occa sionally extending to the chiasm and the optic tracts) on T2weighted MRI (preferably with fat suppression; Figure 1c ). There is usually also swelling of the affected segment of the optic nerve. Moreextensive optic nerve lesions are associated with poor clinical outcomes such as slow and incomplete recovery. 81, 82 Depending on the severity of inflammation, con trast enhancement can be observed on (fatsuppressed) T1weighted images in about 94% of patients with acute optic neuritis. In established optic atrophy from previ ous damage, T2 high signal changes will also be seen, but these changes are associated with thinning of the nerve and do not change over time. Sensitivity of detection of contrastenhancing lesions in the optic nerve can be further increased by using a higher dosage of contrast medium (for example, a triple dose), but in our view this approach is not costeffective. 83, 84 Patients with NMO have a propensity towards exten sive involvement of the anterior visual pathways, and of the intracranial as opposed to the intraorbital segments, making these individuals particularly prone to chiasmitis and simultaneous bilateral disease. 85, 86 Standard care protocol No consensus guidelines have been formulated on how and when to perform optic nerve MRI in cases of optic neuritis. For assessment of the optic nerve, the MRI pro tocol must include fatsuppressed T2weighted images (for example, short tau inversion recovery or frequency specific selective partial inversion recovery) 81 and contrast enhanced (fatsuppressed) T1weighted images (Box 3). The most costeffective approach is to use a standard dosage of gadoliniumbased contrast medium.
T1weighted and T2weighted sequences for the assess ment of the whole orbit and brain are useful to simulta neously detect possible demyelinating brain lesions. For the best spatial resolution, images should be acquired without any interslice gap. The spatial resolution should be 3 mm slice thickness, in plane 1 × 1 mm (measured voxel size 3 × 1 × 1 mm). Additional sagittal proton density weighted/T2weighted (preferably spin echo) and T1weighted postcontrast images of the spinal cord are useful for detecting demyelinating spinal cord lesions and for differential diagnostic purposes (Box 3). Further radiological tests to exclude vascular malformations or vasculitis may be indicated, as summarized in Table 2 .
Research protocol
Although MRI at higher magnetic field strengths (for example, 3 T) does not necessarily lead to an earlier diag nosis of MS, it does result in a higher image quality. 87, 88 In general, a standard head coil is sufficient for the assessment of the orbit and the optic nerves. However, surface coils focusing on the orbit may further improve the image quality. 89 Important MRI methods for research purposes include measures of optic nerve atrophy obtained using high resolution 3D T2weighted sequences, 90 quantitative MRI techniques 91 and diffusion tensor imaging. 92 These advanced techniques can assist in the early detection of clinical impairment, and enable quantitative estimation of the presence and extent of damage to the optic nerve. 93, 94 These measures have all been proposed as markers of irreversible tissue damage and disease progression, and as predictors of clinical recovery.
Electrodiagnostic tests
Overview Electrodiagnostic tests have a role in the investiga tion of atypical presentations of optic neuritis. 95 The tests should not be limited to visual evoked potentials (VEPs), as any retinal abnormality will affect the VEP signal. 95, 96 Indeed, the International Society for Clinical Electrophysiology of Vision (ISCEV) standards 97 rec ommend that in cases of unexplained visual loss, the VEP results should be interpreted in conjunction with both a standard electroretinogram (ERG) and a pattern electroretinogram (PERG). 98 Standard care protocol The ISCEV standards 97 state that electrophysiological tests are of little diagnostic value in acute retrobulbar optic neuritis, but may be useful in studies evaluating therapy. If the diagnosis is uncertain, however, a full series of electrophysiological tests should be performed, as outlined below.
Visual evoked potentials
The VEP represents a specific change in an ongoing EEG recording due to the response of the visual pathway to either a pattern or a flash stimulus. VEPs have been shown to be a highly sensitive but not especially specific test for optic neuritis. A unilateral substantially delayed VEP with minimal amplitude reduction is highly sugges tive of a demyelinating optic neuropathy, for example, recovered MSON or subclinical involvement of the optic nerve in MS. VEP abnormalities will also be seen in patients with refractive errors, pure retinal dysfunc tion, compressive lesions of the optic nerve, Parkinson disease 99 or migraine. 100 Normality of both the ERG and VEP supports the differential diagnosis of nonorganic aetiology if performed after other investigations failed to yield a diagnosis.
Electroretinography
An ERG provides diagnostic information about the rod and cone photoreceptors, and inner retinal function across the entire retina. The differential diagnosis of a pale optic disc with reduced central vision includes cone dystrophies and maculopathies, which will be incorrectly diagnosed if VEPs are used alone.
Research protocol
Multifocal VEPs allow fine mapping of the electro physiological abnormalities in the visual pathway. This mapping enables detection of abnormalities restricted to specific topographies, and may be more sensitive than standard VEPs.
As the macula comprises less than 5% of the retina, a maculopathy will generally not affect the fullfield ERG. The PERG stimulus parameters mean that the macula is the retinal location that is primarily stimulated. 96 The PERG is a surrogate test of macular function, and can, therefore, be used to differentiate macular from optic nerve causes of central vision loss. The two main compo nents of the PERG are N95 and P50, 96, 101, 102 and the N95 component and N95:P50 ratio were found to be useful in optic neuritis. [101] [102] [103] [104] The optic nerve head component responses of multi focal ERG may also emerge as a useful tool in the assessment of optic neuritis. 105 
Perimetry
Overview
The classic visual field defect described in MSON is a central scotoma with a sloping border of the isopters. 106 Of note, however, this feature has only been reported in 2% of cases, 107 and becomes even rarer (0.5%) later in the disease course. Most patients experience a more general ized reduction in their visual field sensitivity (66%). 107 By contrast, altitudinal visual field defects suggest a vascu lar differential diagnosis, 108 and sparing of central vision suggests an optic perineuritis, 109 but neither pattern will rule out optic neuritis.
Automated perimetry should be performed using threshold estimation strategies. 110, 111 An important limi tation, particularly in neurological conditions, children or elderly patients, is that the test is timeconsuming and the failure rate may be up to 46%. [112] [113] [114] One needs to consider operator instruction effects, 'natural variation' in test results, and learning effects. 115, 116 It may not be possible to detect a visual field defect until about 25-35% of retinal ganglion cells have been lost. [117] [118] [119] Therefore, as a consensus, we hesitate to recommend perimetry as a mandatory part of a standard care protocol but, rather, advocate selective use in cases where the test results may guide the differential diagnosis (Table 2) , or in the presence of red flags (Box 1).
Research protocol
Given that production of the Goldmann perimeter has stopped and experience is vanishing, we recommend use of standard threshold automated perimetry. The stimulus size should be Goldmann No. III (0.481°). A visual field of 20-30° should suffice (242 or 302 protocols on the Humphrey Zeiss perimeter; full threshold 32 or static whiteonwhite fields on the Octopus 900 series).
Conclusions and further perspectives
The clinical spectrum of optic neuritis has broadened over the past two decades. This development was driven by several factors: cumulative experience from trials on treatment of optic neuritis; clinical recognition of a divergent semiology; discovery of new autoantibodies and biomarkers; and availability of new highresolution imaging techniques for the optic nerve and retina.
A need exists to make use of this knowledge and these techniques to better investigate and define the clini cal spectrum of optic neuritis with the aim of guiding future patient management. Importantly, some forms of optic neuritis (for example, NMO and CRION) will require rigor ous immunosuppression to protect patients from blindness. It is also essential that patients with these conditions are not included in MSON treatment trials.
We anticipate that the investigation protocol presented here will help us to reach a consensus on the classifica tion of optic neuritis and how to optimize treatment. This consensus should, in turn, be pursued inter nationally so that different approaches can be validated in those parts of the world where MS is less common.
Review criteria
A search for original articles published between 1970 and 2014, focusing on optic neuritis, was performed in Google Scholar, MEDLINE and PubMed. The search terms used were "optic neuritis", "imaging", "MRI", "OCT", "cerebrospinal fluid", "CSF", "biomarker", "immune", "VEP", "ERG", "visual field", "perimetry", "vision", "visual system", "retina" and "optic nerve", alone and in combination. All articles identified were full-text papers in the English language. We also searched the reference lists of identified articles for further relevant papers. Furthermore, specific papers from the literature archives of the authors were included.
